Accuray (ARAY)
(Delayed Data from NSDQ)
$2.07 USD
+0.15 (7.81%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $2.07 0.00 (0.00%) 5:06 PM ET
5-Strong Sell of 5 5
C Value B Growth D Momentum C VGM
Brokerage Reports
Accuray Incorporated [ARAY]
Reports for Purchase
Showing records 161 - 180 ( 234 total )
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Q4?15 TOP LINE BEATS ESTIMATES BUT HIGHER EXPENSE OFFSET BETTER REVENUE
Provider: Obsidian Research Group
Analyst: WANN T
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Continued Progress on Turnaround. Key Points For Investors To Consider. Affirm Buy and $13 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Accuray Incorporated
Industry: Medical - Instruments
Solid Q4 Results and Continued Progress on Turnaround. Orders Encouraging. Expect Strong Revenue Growth And Margin Expansion Going Forward. Affirm Buy and $13 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B